基亞生物科技股份有限公司/Medigen Biotechnology Corp.
基亞生物科技股份有限公司/Medigen Biotechnology Corp.
  • About
    • Company Overview
    • Our Vision
    • Corporate Structure
    • Corporate Governance
      • Board of Directors
      • Remuneration Committee
      • Organization and Operation of Internal Audit
      • Corporate Governance Status
      • Corporate Regulations
      • Corporate Social Responsibility Status
    • Management
    • Careers
    • Subsidiaries
      • Medigen Vaccine Biologics Corporation
      • TBG Diagnostics Limited
      • Winston Medical & Biotech Group
  • Cell Therapy
    • MAGICELLl–NK (Natural killer cells)
    • MAGICELL®-GDT​(T cells)
    • GTP certificated cell processing facility
    • Cell Therapy Cooperation Agency
    • Cell Therapy Regulation in Taiwan
  • COVID-19
  • CLINICAL TRIALS
    • Product Pipelines
    • NK CELL (MAGICELL-NK)
    • OBP-301 (Telomelysin)​
  • NEWS
    • Material Information
      • 2025
      • 2024
      • 2023
      • 2021
    • Financial Statement
    • Shareholder Services
  • Investors
    • Financial Statements
      • Monthly Revenue Statement
      • Quarterly and Annual Report
    • Shareholder Services
      • Share Price
      • Shareholder Meeting Document
    • Contact Information
    • Stakeholders
  • Language
    • 中文 (繁)
    • English
    • 中文 (简)

Posts by Teddy

Home | Posts by Teddy

2015 Annual Report

0
By Teddy
2019-01-29
Financial Statement

read more

CellMax Life to Provide Blood Test for Medigen Biotech’s Colorectal Cancer Cell Therapy Clinical Trials

0
By Teddy
2019-01-28
NEWS

read more

TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation

0
By Teddy
2017-10-31
NEWS

read more

MVC co-organized international forum for dengue prevention and vaccine development

0
By Teddy
2017-10-19
NEWS

read more

A Phase III Trial of Muparfostat (PI-88) as Adjuvant Therapy in Patients with Hepatitis Virus Related Hepatocellular Carcinoma (HV-HCC) after Resection

0
By Teddy
2017-09-08
NEWS

read more

Winston receives the Excellence Award for 2016 Government Uniform Invoice (GUI) — Issuing Business Operator from the Ministry of Finance(MOF), Taiwan

0
By Teddy
2017-09-08
NEWS

read more

MVC obtains TFDA’s approval to initiate EV71 vaccine’s phase 3 CT

0
By Teddy
2017-08-08
NEWS

read more

TBG ExProbe™ Real Time PCR Based Typing Kit receives Taiwan FDA approval and CE Mark, immediately opens markets

0
By Teddy
2017-08-08
NEWS

read more

Enrollment of first patient in melanoma phase II clinical trial for Telomelysin® (OBP-301) in the US

0
By Teddy
2017-08-07
NEWS

read more

The First EV71 Vaccine Protecting 2 ~6 Months Old Babies Wins Taiwan’s National Innovation Award

0
By Teddy
2017-01-03
NEWS

read more
  • News
  • Financial Statement
  • Shareholder Services
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
14F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan (R.O.C)‧Copyright© 2021-2025 Medigen Biotechnology Corp. All rights reserved.